相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis
Andrea Schampel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Intravital real-time analysis of T-cell activation in health and disease
Dmitri Lodygin et al.
CELL CALCIUM (2017)
WT1 and interferon-β-vitamin D association in MS: a longitudinal study
T. Holmoy et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis
Elias S. Sotirchos et al.
NEUROLOGY (2016)
Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis
Zarintaj Malihi et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study
Anne-Hilde Muris et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Chunrong Tao et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light
Yanping Wang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab
Julie Hejgaard Laursen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis
Alvaro Cobo-Calvo et al.
EUROPEAN NEUROLOGY (2015)
NKT cells can help mediate the protective effects of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis in mice
Amanda Waddell et al.
INTERNATIONAL IMMUNOLOGY (2015)
Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients
Bahar Naghavi Gargari et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
The L-type voltage-gated calcium channel modulates microglial pro-inflammatory activity
J. F. Espinosa-Parrilla et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
Regulation of Dendritic Cell Function by Vitamin D
Myriam Barragan et al.
NUTRIENTS (2015)
Modulating effects of WT1 on interferon-beta-vitamin D association in MS
R. Lin et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Ultraviolet B Light Attenuates the Systemic Immune Response in Central Nervous System Autoimmunity
Johanna Breuer et al.
ANNALS OF NEUROLOGY (2014)
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: Study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis
Pavan Bhargava et al.
CONTEMPORARY CLINICAL TRIALS (2014)
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D
Yara Dadalti Fragoso et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study
Kjetil Bjornevik et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
1,25-Dihydroxyvitamin D3 and Its Analog TX527 Promote a Stable Regulatory T Cell Phenotype in T Cells from Type 1 Diabetes Patients
Tom L. Van Belle et al.
PLOS ONE (2014)
Vitamin D supplementation for prevention of mortality in adults
Goran Bjelakovic et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
Alison Avenell et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid
Jorge Correale et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Severe Hypercalcemia Following Vitamin D Supplementation in a Patient With Multiple Sclerosis A Note of Caution
Jacqueline F. Marcus et al.
ARCHIVES OF NEUROLOGY (2012)
The role of 1a,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+and IL-10+CD4+T cells
Zoe Urry et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Vitamin D in multiple sclerosis: implications for assessment and treatment
Trygve Holmoy et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
1,25-Dihydroxyvitamin D Exerts Similar Immunosuppressive Effects as UVR but Is Dispensable for Local UVR-Induced Immunosuppression
Agatha Schwarz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
Merja Soilu-Hanninen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment
Kristin I. Loken-Amsrud et al.
NEUROLOGY (2012)
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS
Niall Stewart et al.
NEUROLOGY (2012)
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis
Tessel F. Runia et al.
NEUROLOGY (2012)
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
Jan Doerr et al.
TRIALS (2012)
Smoking: effects on multiple sclerosis susceptibility and disease progression
Dean M. Wingerchuk
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis
Christopher G. Mayne et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells
Ai-Leng Khoo et al.
IMMUNOLOGY (2011)
Lineage-specific Effects of 1,25-Dihydroxyvitamin D3 on the Development of Effector CD4 T Cells
Matthew T. Palmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
M. S. Stein et al.
NEUROLOGY (2011)
Sun exposure and vitamin D are independent risk factors for CNS demyelination
R. M. Lucas et al.
NEUROLOGY (2011)
1,25-Dihydroxyvitamin D-3 Modulates Th17 Polarization and Interleukin-22 Expression by Memory T Cells From Patients With Early Rheumatoid Arthritis
E. M. Colin et al.
ARTHRITIS AND RHEUMATISM (2010)
Primary effect of 1α,25(OH)2D3 on IL-10 expression in monocytes is short-term down-regulation
Juha M. Matilainen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells
Jian Ma et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells
Utako Ikeda et al.
IMMUNOLOGY LETTERS (2010)
Therapeutic Effect of EDTA in Experimental Model of Multiple Sclerosis
G. Mosayebi et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2010)
Vitamin D Suppresses Th17 Cytokine Production by Inducing C/EBP Homologous Protein (CHOP) Expression
Seon Hee Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Effects of Vitamin D3 on Expression of Tumor Necrosis Factor-α and Chemokines by Monocytes
Yu-Ting Kuo et al.
JOURNAL OF FOOD SCIENCE (2010)
Stromal Interaction Molecules 1 and 2 Are Key Regulators of Autoreactive T Cell Activation in Murine Autoimmune Central Nervous System Inflammation
Michael K. Schuhmann et al.
JOURNAL OF IMMUNOLOGY (2010)
Epstein-Barr Virus Infection and Multiple Sclerosis: A Review
Alberto Ascherio et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Vitamin D and multiple sclerosis
Alberto Ascherio et al.
LANCET NEUROLOGY (2010)
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
J. M. Burton et al.
NEUROLOGY (2010)
Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis
Joost Smolders et al.
PLOS ONE (2010)
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production
Bryan R. Becklund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Immunomodulatory effects of Vitamin D in multiple sclerosis
Jorge Correale et al.
BRAIN (2009)
1 alpha,25-Dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in Human Monocytes
Cristiana Almerighi et al.
CYTOKINE (2009)
1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3
Louisa E. Jeffery et al.
JOURNAL OF IMMUNOLOGY (2009)
Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
Joost Smolders et al.
PLOS ONE (2009)
Monster protein controls calcium entry and fights infection
Amy N. Radermacher et al.
IMMUNITY (2008)
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
J. Smolders et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Recent advances in urocanic acid photochemistry, photobiology and photoimmunology
Neil K. Gibbs et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2008)
1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+T cells from patients with Crohn's disease
Lars Erik Bartels et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Cell defenses and the sunshine vitamin
Luz E. Tavera et al.
SCIENTIFIC AMERICAN (2007)
1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking
Laura B. Pedersen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation
Sheng Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
I. A. F. van der Mei et al.
JOURNAL OF NEUROLOGY (2007)
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
Kassandra L. Munger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The vitamin D epidemic and its health consequences
MF Holick
JOURNAL OF NUTRITION (2005)
Interactions of 1α,25-dihydroxyvitamin D3 with IL-12 and IL-4 on cytokine expression of human T lymphocytes
R Thien et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
1α,25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cells
B Decallonne et al.
JOURNAL OF AUTOIMMUNITY (2005)
Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis
E Brand-Schieber et al.
EXPERIMENTAL NEUROLOGY (2004)
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
MF Holick
AMERICAN JOURNAL OF CLINICAL NUTRITION (2004)
Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line
CL d'Hellencourt et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Cytokine profile in patients with multiple sclerosis following vitamin D supplementation
BD Mahon et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D3
AGS van Halteren et al.
DIABETES (2002)
Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes
M Cippitelli et al.
JOURNAL OF IMMUNOLOGY (2002)
1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells
A Boonstra et al.
JOURNAL OF IMMUNOLOGY (2001)
Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis
FE Nashold et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs:: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo
MD Griffin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Evidence of functional vitamin D receptors in rat hippocampus
MC Langub et al.
NEUROSCIENCE (2001)
Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells
L Piemonti et al.
JOURNAL OF IMMUNOLOGY (2000)
Identification and immune regulation of 25-hydroxyvitamin D-1-α-hydroxylase in murine macrophages
L Overbergh et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system
CM Veldman et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
1 alpha,25-dihydroxyvitamin D-3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation
G Penna et al.
JOURNAL OF IMMUNOLOGY (2000)
1,25-dihydroxyvitamin D-3 treatment decreases macrophage accumulation in the CNS elf mice with experimental autoimmune encephalomyelitis
FE Nashold et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
分享论文
